Company / Profit Margin
Beta Bionics, Inc. Profit Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-73.0%
FY2025
5-year range
-84.1% / -73.0%
FY2024-FY2025
Trend
+13.2%
vs FY2024
Sector context
#149 of 156
Health Care
What the data says
Among 156 Health Care companies, Beta Bionics, Inc. is in the bottom 4% for profit margin.
Based on SEC 10-K filings.
-73.0% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 156This company -73.0% Sector average -252.5%
▼
+71.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 13.2% year-over-year.
- Currently 179.5pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -73.0% | +13.2% |
| FY2024 | -84.1% | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026